The Effect of Anlotinib Combined with anti-PD-1 in the Treatment of Gastric Cancer

BACKGROUND: Protein tyrosine kinase (PTK) signaling pathway has been confirmed to be involved in the proliferation, differentiation and migration of tumor cells. Anlotinib, as a multi-target tyrosine kinase inhibitor, which can inhibit the expression of vascular endothelial growth factor receptor (V...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wubin, Sun, Guoqiang, Li, Zhitao, Wu, Fan, Sun, Guangshun, Cao, Hongyong, Zhou, Jin, Ma, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039330/
https://www.ncbi.nlm.nih.gov/pubmed/35495754
http://dx.doi.org/10.3389/fsurg.2022.895982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039330/
https://www.ncbi.nlm.nih.gov/pubmed/35495754
http://dx.doi.org/10.3389/fsurg.2022.895982

Ejemplares similares